[Controversies regarding the effects of cyclooxygenase inhibitors on the course and complications of arterial atherosclerosis].
Tuleja
Ewa
E
II Katedra Chorób Wewnetrznych, Collegium Medicum Uniwersytetu Jagiellońskiego, Kraków, Poland.
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects; D001161:Arteriosclerosis / Q000150:complications* / Q000188:drug therapy* / Q000378:metabolism; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans
D000894:Anti-Inflammatory Agents, Non-Steroidal; D016861:Cyclooxygenase Inhibitors